1992
DOI: 10.1016/s0750-7658(05)80018-8
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacologie de la nalbuphine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1992
1992
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…The respiratory depression induced by opioids is primarily mediated by the μ-receptor agonist activity. The μ-antagonist properties of the nalbuphine should produce fewer μ-mediated side effects such as respiratory depression, pruritus, nausea and vomiting 13,14 .…”
Section: Introductionmentioning
confidence: 99%
“…The respiratory depression induced by opioids is primarily mediated by the μ-receptor agonist activity. The μ-antagonist properties of the nalbuphine should produce fewer μ-mediated side effects such as respiratory depression, pruritus, nausea and vomiting 13,14 .…”
Section: Introductionmentioning
confidence: 99%
“…Although nalbuphine is an old drug, because of its history it is not well studied, especially in relation to the dose adjustment required due to obesity [ 2 ]. It is known to have comparable water solubility to morphine [ 3 ], so we assumed that it behaves mostly like morphine (the literature is not completely in agreement about this). It is common practice not to adjust the morphine dose for body weight, as it is the lean body weight, not the total body weight, that is relevant to drug clearance.…”
mentioning
confidence: 99%